H&E and Ki67 staining revealed a significant decrease in areas with tumor cells (H&E) in the ODC‐treated group, and proliferating nuclei in the ODC and vemurafenib‐treated groups, as compared to the control and monotherapies. Here, MKI67 is linked to neoplasm.